A COST-EFFECTIVENESS ANALYSIS OF COMMONLY USED BIOLOGIC DRUGS FOR THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE UNITED STATES

被引：0
|
作者：
Wu, J. J. [1 ]
Feldman, S. R. [2 ]
Rastogi, S. [3 ]
Menges, B. [4 ]
Lingohr-Smith, M. [4 ]
Lin, J. [4 ]
机构：
[1] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[3] Ortho Dermatol, Bridgewater, NJ USA
[4] Novosys Hlth, Green Brook, NJ USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1630
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS8
引用
收藏
页码：S240 / S240
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis
    Wu, Bin
    Wang, Zhenhua
    Zhang, Qiang
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2291 - 2302
  • [42] Cost-effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China
    Kim, Soyoung
    Ooi, Adrian Yit Reen
    Stephens, Thomas
    Jiang, Hongsi
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1125 - 1141
  • [43] Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States
    Anis, Aslam H.
    Bansback, Nick
    Sizto, Sonia
    Gupta, Shiraz R.
    Willian, Mary K.
    Feldman, Steve R.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2011, 22 (02) : 65 - 74
  • [44] Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting
    Denise Küster
    Alexander Nast
    Sascha Gerdes
    Tobias Weberschock
    Gottfried Wozel
    Mandy Gutknecht
    Jochen Schmitt
    [J]. Archives of Dermatological Research, 2016, 308 : 249 - 261
  • [45] Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting
    Kuester, Denise
    Nast, Alexander
    Gerdes, Sascha
    Weberschock, Tobias
    Wozel, Gottfried
    Gutknecht, Mandy
    Schmitt, Jochen
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2016, 308 (04) : 249 - 261
  • [46] COST-EFFECTIVENESS OF BRODALUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Kontodimas, S.
    Kourlaba, G.
    [J]. VALUE IN HEALTH, 2018, 21 : S428 - S428
  • [47] Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system
    Greiner, R. -A.
    Braathen, L. R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1427 - 1427
  • [48] Cost-effectiveness of biologics for moderate-to-severe psoriasis from the perspective of the Swiss healthcare system
    Greiner, Roger-Axel
    Braathen, Lasse R.
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (05) : 494 - 499
  • [49] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Villacorta, Reginald
    Hay, Joel W.
    Messali, Andrew
    [J]. PHARMACOECONOMICS, 2013, 31 (09) : 823 - 839
  • [50] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Reginald Villacorta
    Joel W. Hay
    Andrew Messali
    [J]. PharmacoEconomics, 2013, 31 : 823 - 839
12345